Dámaso Molero
Amministratore Delegato presso 3P Biopharmaceuticals SL
Profilo
Dámaso Molero is currently the Chief Executive Officer at 3P Biopharmaceuticals SL.
Previously, he held positions as Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche & Genentech, Inc. He obtained his undergraduate degree and MBA from the University of Navarra.
Posizioni attive di Dámaso Molero
| Società | Posizione | Inizio |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Amministratore Delegato | 01/04/2007 |
Precedenti posizioni note di Dámaso Molero
| Società | Posizione | Fine |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
Formazione di Dámaso Molero
| University of Navarra | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Syntex, Inc. | Miscellaneous |
| Glaxo, Inc. |
- Borsa valori
- Insiders
- Dámaso Molero
